This is not a gray area
Semaglutide, originally used for type 2 diabetes, helps lower blood sugar levels by increasing the amount of insulin production after eating
Unfortunately, doctors dont usually test for insulin resistance, even if you suspect it, because no single test can detect it
This introductory phase allows the body to adjust to the medication while minimizing potential side effects, such as nausea
With Medicare in 2025, here's what to expect: Medicare may cover semaglutide for diabetes, but it may not cover weight loss You might pay up to $590 per year before coverage starts (the deductible) After that, you will have to pay a portion of the cost (copay or coinsurance) In 2025, after meeting your deductible, you pay 25% of drug costs until you've spent a total of $2,000
Clinical trials and patient reports often note renewed weight loss after a semaglutide plateau, though individual results vary and shouldnt replace medical guidance